Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meditope Biosciences
Pasadena, California, United Statesmeditope.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Preclinical
01
Overview
Meditope is developing a preclinical pipeline of cancer drugs using their proprietary SnAP technology, which allows for site-specific attachment of various molecules to antibodies without chemical conjugation.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-based therapeuticsAntibody-drug conjugates (ADCs)Meditope-enabled Antibody Radioisotope Conjugate (MeARC)
- Industry
- Biotech
02
Partnerships
City of Hope National Medical Center
Beyond the preview
Go deeper on Meditope Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meditope Biosciences.